Q/C Technologies, Inc.
Diagnostics company · New York, United States · Nasdaq: QCLS
Q/C Technologies, Inc. is a diagnostics company headquartered in New York, United States. Its earliest recorded incorporation is in 2023. Its shares trade on Nasdaq under the ticker QCLS. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2025.
Q/C Technologies at a glance
What does Q/C Technologies do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $7 million sold (2025).
Frequently asked questions about Q/C Technologies
Where is Q/C Technologies headquartered?
Q/C Technologies, Inc. is headquartered in New York, United States.
What does Q/C Technologies do?
Q/C Technologies, Inc. is a diagnostics company. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.
Is Q/C Technologies a public company?
Yes. Q/C Technologies, Inc. trades on Nasdaq under the ticker QCLS.
When was Q/C Technologies founded?
The earliest incorporation on record for Q/C Technologies, Inc. is in 2023, according to public company registers.
Similar companies
- Bioscience Development IncNew York City, New York, United States
- Clear Session, IncNew York City, New York, United States
- MDDx, Inc.New York City, New York, United States
- Foli Bio Inc.New York City, New York, United States
- Tiffany ST BernardNew York City, New York, United States
- Augnition Labs LLCNew York City, New York, United States
- Quicksilver Biosciences IncNew York City, New York, United States
- Kognito Solutions, LLCNew York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences